Aurinia Pharmaceuticals Inc (AUPH) 已宣布,将于2026年2月26日发布其截至2025年12月31日的第四季度及全年财务业绩报告。届时,公司管理层不仅会详细解读财报数据,还将同步介绍公司近期的关键业务动态与战略进展。此次发布将为投资者和市场观察人士提供一个全面了解公司财务状况与运营成效的重要窗口。
Aurinia Pharmaceuticals Inc (AUPH) 已宣布,将于2026年2月26日发布其截至2025年12月31日的第四季度及全年财务业绩报告。届时,公司管理层不仅会详细解读财报数据,还将同步介绍公司近期的关键业务动态与战略进展。此次发布将为投资者和市场观察人士提供一个全面了解公司财务状况与运营成效的重要窗口。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.